Neuroblastoma Occurring in Nijmegen Breakage Syndrome
- PMID: 39737638
- DOI: 10.1097/MPH.0000000000002965
Neuroblastoma Occurring in Nijmegen Breakage Syndrome
Abstract
Nijmegen breakage syndrome (NBS) is a rare primary immunodeficiency disease due to a pathogenic variant in the NBN gene causing impaired DNA repair and increased predisposition for lymphoid malignancy. By contrast, solid tumors have been rarely reported. Neuroblastoma (NB) is a rare childhood solid tumor, associated with the worse outcome if MYCN oncogene is amplified. We describe 2 young pediatric patients with NBS who developed high-risk NB. The first patient died shortly after chemotherapy was introduced. The second patient successfully received modified chemotherapy resulting in clinical remission lasting 2 years after an initial diagnosis of NB.
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Varon R, Demuth I, Chrzanowska KH. Nijmegen breakage syndrome. Gene Reviews. 1999. https://www.ncbi.nlm.nih.gov/books/NBK1176/
-
- Westermann F, Schwab M. Genetic parameters of neuroblastomas. Cancer Lett. 2002;184:127–147.
-
- Monclair T, Brodeur GM, Ambros PF, et al. The International Neuroblastoma Risk Group (INRG) Staging System: an INRG Task Force report. INRG Task Force. J Clin Oncol. 2009;27:298–303.
-
- Wegner RD, German JJ, Chrzanowska KH, et al. Chromosomal instability syndromes other than ataxia-telangiectasia. In: Ochs HD, Smith CIE, Puck JM, eds. Primary Immunodeficiency Diseases: A Molecular and Genetic Approach, 2nd ed. New York, NY: Oxford University Press; 2007:4527–4532.
-
- Rossa A, Cacciavillano W, Rose A, et al. Neuroblastoma in patients under 18 months. Single institution experience in Argentina. Medicina (B Aires). 2019;79:280–283.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
